Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocular diseases.
ADVM | US
Overview
Corporate Details
- ISIN(s):
- US00773U2078
- LEI:
- Country:
- United States of America
- Address:
- 100 CARDINAL WAY, 94063 REDWOOD CITY
- Website:
- https://adverum.com/
- Sector:
- Manufacturing
Description
Adverum Biotechnologies, Inc. is a clinical-stage company developing gene therapies for highly prevalent ocular diseases. The company's primary goal is to establish single-administration intravitreal (IVT) gene therapy as a new standard of care, aspiring to develop functional cures that restore vision and prevent blindness. Its lead product candidate, Ixo-vec (ixoberogene soroparvovec), targets wet age-related macular degeneration (wet AMD). Adverum utilizes a proprietary adeno-associated virus (AAV) vector platform designed to transform retinal cells into biofactories for the long-term production of therapeutic proteins. This approach aims to replace the need for frequent eye injections with a durable, in-office treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Adverum Biotechnologies, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Adverum Biotechnologies, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Adverum Biotechnologies, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
